Trial intelligence / Profile preview

Comparison of iron kinetics maintenance from darbepoetin to epoetin beta pegol in hemodialysis patients

jRCT1090220252Completed

Sponsor
shogo kimura
Start
Jun 2016
Modality
Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Open-label trial of methoxy polyethylene glycol-epoetin beta in anemia of renal disease (2 arms), sponsored by shogo kimura. Primary endpoint: Change in Hb, ferritin, TSAT, hepcidin-25, MCV, and ERI from baseline to end of observation. Started Jun 2016; status: completed.

02

Drugs

methoxy polyethylene glycol-epoetin beta
03

Conditions

anemia of renal disease

Beyond the preview

Go deeper on jRCT1090220252.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1090220252.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call